A triple-antibiotic combination completely eliminated antibiotic-resistant Mycobacterium abscessus, a bacterial infection especially dangerous to…
Articles by Steve Bryson, PhD
Low birth weight and poor weight gain in the first year of life in infants with cystic…
Inhibition of the interleukin-1 receptor — to block thick mucus production and inflammation — is a potential strategy…
A biosimilar of dornase alfa inhalation solution, with the same therapeutic activity as …
Armata Pharmaceuticals is going to target multidrug-resistant Pseudomonas aeruginosa infections in…
Single dosing of orally inhaled POL6014, an experimental therapy to treat chronic lung inflammation, can effectively block…
Amikacin liposome inhalation suspension (ALIS)Â showed the same efficacy and similar safety profile as tobramycin inhalation solution (TIS) for the treatment…
Blocking a pro-inflammatory protein complex, broadly known as the neutrophil inflammasome, represents a new way of treating chronic…
Clinical centers with high screening rates for cystic fibrosis-related diabetes (CFRD) were more likely to achieve early…
Pulmonary infection with a specific species of the Mycobacterium avium complex (MAC), called Mycobacterium intracellulare, can be aggressive in…